Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-03-19 00:00:00 ET · period of report 2026-03-17 · accession 0001628280-26-019847 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-17 | BMRN | Hardy Alexander | CEO, Dir | F - Tax | $56.05 | -4,252 | 214.6K | -2% | -$238.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | F | D | 4,252 | $56.05 | 214,635 | D | — | — |